Fitzpatrick Alexander A 4
4 · ARS Pharmaceuticals, Inc. · Filed Oct 2, 2023
Insider Transaction Report
Form 4
Fitzpatrick Alexander A
Chief Legal Officer
Transactions
- Purchase
Common Stock
2023-09-28$3.62/sh+40,000$144,960→ 42,969 total - Purchase
Common Stock
2023-09-29$3.78/sh+46,258$174,994→ 89,227 total
Footnotes (3)
- [F1]The price reported in Column 4 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.60 to $3.64, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F2]Includes 2,969 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2023.
- [F3]The price reported in Column 4 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.70 to $3.85, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.